The research team projects that the Pharmaceutical CDMO Services market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
WuXi AppTec Group
Strides Pharma Science Limited
Aenova Group
AMRI Global
Recipharm AB
Patheon N.V.
Siegfried Ltd
Amatsigroup
Catalent, Inc.
Piramal Pharma Solutions
Fareva Group
FAMAR Health Care Services
By Type
Drug Substance Development and Manufacturing
Specialized Services
Lab-based Services
By Application
Innovative Medicine
Patented Drug
Patent Expired Drug
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
Russia
Spain
Netherlands
Switzerland
Poland
South Asia
India
Pakistan
Bangladesh
Southeast Asia
Indonesia
Thailand
Singapore
Malaysia
Philippines
Vietnam
Myanmar
Middle East
Turkey
Saudi Arabia
Iran
United Arab Emirates
Israel
Iraq
Qatar
Kuwait
Oman
Africa
Nigeria
South Africa
Egypt
Algeria
Morocoo
Oceania
Australia
New Zealand
South America
Brazil
Argentina
Colombia
Chile
Venezuela
Peru
Puerto Rico
Ecuador
Rest of the World
Kazakhstan
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Pharmaceutical CDMO Services 2016-2021, and development forecast 2022-2027 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2021 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2022-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Pharmaceutical CDMO Services Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).
Markat Analysis by Application Type: Based on the Pharmaceutical CDMO Services Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Pharmaceutical CDMO Services market in 2021. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Pharmaceutical CDMO Services Market Size Analysis from 2022 to 2027
1.5.1 Global Pharmaceutical CDMO Services Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Pharmaceutical CDMO Services Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Pharmaceutical CDMO Services Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Pharmaceutical CDMO Services Industry Impact
Chapter 2 Global Pharmaceutical CDMO Services Competition by Types, Applications, and Top Regions and Countries
2.1 Global Pharmaceutical CDMO Services (Volume and Value) by Type
2.1.1 Global Pharmaceutical CDMO Services Consumption and Market Share by Type (2016-2021)
2.1.2 Global Pharmaceutical CDMO Services Revenue and Market Share by Type (2016-2021)
2.2 Global Pharmaceutical CDMO Services (Volume and Value) by Application
2.2.1 Global Pharmaceutical CDMO Services Consumption and Market Share by Application (2016-2021)
2.2.2 Global Pharmaceutical CDMO Services Revenue and Market Share by Application (2016-2021)
2.3 Global Pharmaceutical CDMO Services (Volume and Value) by Regions
2.3.1 Global Pharmaceutical CDMO Services Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Pharmaceutical CDMO Services Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Pharmaceutical CDMO Services Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Pharmaceutical CDMO Services Consumption by Regions (2016-2021)
4.2 North America Pharmaceutical CDMO Services Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Pharmaceutical CDMO Services Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Pharmaceutical CDMO Services Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Pharmaceutical CDMO Services Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Pharmaceutical CDMO Services Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Pharmaceutical CDMO Services Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Pharmaceutical CDMO Services Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Pharmaceutical CDMO Services Sales, Consumption, Export, Import (2016-2021)
4.10 South America Pharmaceutical CDMO Services Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Pharmaceutical CDMO Services Market Analysis
5.1 North America Pharmaceutical CDMO Services Consumption and Value Analysis
5.1.1 North America Pharmaceutical CDMO Services Market Under COVID-19
5.2 North America Pharmaceutical CDMO Services Consumption Volume by Types
5.3 North America Pharmaceutical CDMO Services Consumption Structure by Application
5.4 North America Pharmaceutical CDMO Services Consumption by Top Countries
5.4.1 United States Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
5.4.2 Canada Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
5.4.3 Mexico Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
Chapter 6 East Asia Pharmaceutical CDMO Services Market Analysis
6.1 East Asia Pharmaceutical CDMO Services Consumption and Value Analysis
6.1.1 East Asia Pharmaceutical CDMO Services Market Under COVID-19
6.2 East Asia Pharmaceutical CDMO Services Consumption Volume by Types
6.3 East Asia Pharmaceutical CDMO Services Consumption Structure by Application
6.4 East Asia Pharmaceutical CDMO Services Consumption by Top Countries
6.4.1 China Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
6.4.2 Japan Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
6.4.3 South Korea Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
Chapter 7 Europe Pharmaceutical CDMO Services Market Analysis
7.1 Europe Pharmaceutical CDMO Services Consumption and Value Analysis
7.1.1 Europe Pharmaceutical CDMO Services Market Under COVID-19
7.2 Europe Pharmaceutical CDMO Services Consumption Volume by Types
7.3 Europe Pharmaceutical CDMO Services Consumption Structure by Application
7.4 Europe Pharmaceutical CDMO Services Consumption by Top Countries
7.4.1 Germany Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
7.4.2 UK Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
7.4.3 France Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
7.4.4 Italy Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
7.4.5 Russia Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
7.4.6 Spain Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
7.4.7 Netherlands Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
7.4.8 Switzerland Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
7.4.9 Poland Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
Chapter 8 South Asia Pharmaceutical CDMO Services Market Analysis
8.1 South Asia Pharmaceutical CDMO Services Consumption and Value Analysis
8.1.1 South Asia Pharmaceutical CDMO Services Market Under COVID-19
8.2 South Asia Pharmaceutical CDMO Services Consumption Volume by Types
8.3 South Asia Pharmaceutical CDMO Services Consumption Structure by Application
8.4 South Asia Pharmaceutical CDMO Services Consumption by Top Countries
8.4.1 India Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
8.4.2 Pakistan Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Pharmaceutical CDMO Services Market Analysis
9.1 Southeast Asia Pharmaceutical CDMO Services Consumption and Value Analysis
9.1.1 Southeast Asia Pharmaceutical CDMO Services Market Under COVID-19
9.2 Southeast Asia Pharmaceutical CDMO Services Consumption Volume by Types
9.3 Southeast Asia Pharmaceutical CDMO Services Consumption Structure by Application
9.4 Southeast Asia Pharmaceutical CDMO Services Consumption by Top Countries
9.4.1 Indonesia Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
9.4.2 Thailand Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
9.4.3 Singapore Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
9.4.4 Malaysia Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
9.4.5 Philippines Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
9.4.6 Vietnam Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
9.4.7 Myanmar Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
Chapter 10 Middle East Pharmaceutical CDMO Services Market Analysis
10.1 Middle East Pharmaceutical CDMO Services Consumption and Value Analysis
10.1.1 Middle East Pharmaceutical CDMO Services Market Under COVID-19
10.2 Middle East Pharmaceutical CDMO Services Consumption Volume by Types
10.3 Middle East Pharmaceutical CDMO Services Consumption Structure by Application
10.4 Middle East Pharmaceutical CDMO Services Consumption by Top Countries
10.4.1 Turkey Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
10.4.3 Iran Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
10.4.5 Israel Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
10.4.6 Iraq Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
10.4.7 Qatar Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
10.4.8 Kuwait Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
10.4.9 Oman Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
Chapter 11 Africa Pharmaceutical CDMO Services Market Analysis
11.1 Africa Pharmaceutical CDMO Services Consumption and Value Analysis
11.1.1 Africa Pharmaceutical CDMO Services Market Under COVID-19
11.2 Africa Pharmaceutical CDMO Services Consumption Volume by Types
11.3 Africa Pharmaceutical CDMO Services Consumption Structure by Application
11.4 Africa Pharmaceutical CDMO Services Consumption by Top Countries
11.4.1 Nigeria Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
11.4.2 South Africa Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
11.4.3 Egypt Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
11.4.4 Algeria Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
11.4.5 Morocco Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
Chapter 12 Oceania Pharmaceutical CDMO Services Market Analysis
12.1 Oceania Pharmaceutical CDMO Services Consumption and Value Analysis
12.2 Oceania Pharmaceutical CDMO Services Consumption Volume by Types
12.3 Oceania Pharmaceutical CDMO Services Consumption Structure by Application
12.4 Oceania Pharmaceutical CDMO Services Consumption by Top Countries
12.4.1 Australia Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
12.4.2 New Zealand Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
Chapter 13 South America Pharmaceutical CDMO Services Market Analysis
13.1 South America Pharmaceutical CDMO Services Consumption and Value Analysis
13.1.1 South America Pharmaceutical CDMO Services Market Under COVID-19
13.2 South America Pharmaceutical CDMO Services Consumption Volume by Types
13.3 South America Pharmaceutical CDMO Services Consumption Structure by Application
13.4 South America Pharmaceutical CDMO Services Consumption Volume by Major Countries
13.4.1 Brazil Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
13.4.2 Argentina Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
13.4.3 Columbia Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
13.4.4 Chile Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
13.4.5 Venezuela Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
13.4.6 Peru Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
13.4.8 Ecuador Pharmaceutical CDMO Services Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Pharmaceutical CDMO Services Business
14.1 WuXi AppTec Group
14.1.1 WuXi AppTec Group Company Profile
14.1.2 WuXi AppTec Group Pharmaceutical CDMO Services Product Specification
14.1.3 WuXi AppTec Group Pharmaceutical CDMO Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Strides Pharma Science Limited
14.2.1 Strides Pharma Science Limited Company Profile
14.2.2 Strides Pharma Science Limited Pharmaceutical CDMO Services Product Specification
14.2.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Aenova Group
14.3.1 Aenova Group Company Profile
14.3.2 Aenova Group Pharmaceutical CDMO Services Product Specification
14.3.3 Aenova Group Pharmaceutical CDMO Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 AMRI Global
14.4.1 AMRI Global Company Profile
14.4.2 AMRI Global Pharmaceutical CDMO Services Product Specification
14.4.3 AMRI Global Pharmaceutical CDMO Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Recipharm AB
14.5.1 Recipharm AB Company Profile
14.5.2 Recipharm AB Pharmaceutical CDMO Services Product Specification
14.5.3 Recipharm AB Pharmaceutical CDMO Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 Patheon N.V.
14.6.1 Patheon N.V. Company Profile
14.6.2 Patheon N.V. Pharmaceutical CDMO Services Product Specification
14.6.3 Patheon N.V. Pharmaceutical CDMO Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 Siegfried Ltd
14.7.1 Siegfried Ltd Company Profile
14.7.2 Siegfried Ltd Pharmaceutical CDMO Services Product Specification
14.7.3 Siegfried Ltd Pharmaceutical CDMO Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 Amatsigroup
14.8.1 Amatsigroup Company Profile
14.8.2 Amatsigroup Pharmaceutical CDMO Services Product Specification
14.8.3 Amatsigroup Pharmaceutical CDMO Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Catalent, Inc.
14.9.1 Catalent, Inc. Company Profile
14.9.2 Catalent, Inc. Pharmaceutical CDMO Services Product Specification
14.9.3 Catalent, Inc. Pharmaceutical CDMO Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Piramal Pharma Solutions
14.10.1 Piramal Pharma Solutions Company Profile
14.10.2 Piramal Pharma Solutions Pharmaceutical CDMO Services Product Specification
14.10.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Fareva Group
14.11.1 Fareva Group Company Profile
14.11.2 Fareva Group Pharmaceutical CDMO Services Product Specification
14.11.3 Fareva Group Pharmaceutical CDMO Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 FAMAR Health Care Services
14.12.1 FAMAR Health Care Services Company Profile
14.12.2 FAMAR Health Care Services Pharmaceutical CDMO Services Product Specification
14.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Pharmaceutical CDMO Services Market Forecast (2022-2027)
15.1 Global Pharmaceutical CDMO Services Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Pharmaceutical CDMO Services Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Pharmaceutical CDMO Services Value and Growth Rate Forecast (2022-2027)
15.2 Global Pharmaceutical CDMO Services Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Pharmaceutical CDMO Services Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Pharmaceutical CDMO Services Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Pharmaceutical CDMO Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Pharmaceutical CDMO Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Pharmaceutical CDMO Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Pharmaceutical CDMO Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Pharmaceutical CDMO Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Pharmaceutical CDMO Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Pharmaceutical CDMO Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Pharmaceutical CDMO Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Pharmaceutical CDMO Services Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Pharmaceutical CDMO Services Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Pharmaceutical CDMO Services Consumption Forecast by Type (2022-2027)
15.3.2 Global Pharmaceutical CDMO Services Revenue Forecast by Type (2022-2027)
15.3.3 Global Pharmaceutical CDMO Services Price Forecast by Type (2022-2027)
15.4 Global Pharmaceutical CDMO Services Consumption Volume Forecast by Application (2022-2027)
15.5 Pharmaceutical CDMO Services Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Request Sample 
Request Discount 
Inquire Before Buy
